Abnormal activation of YAP/TAZ is detected in many solid tumours, including breast cancer, cholangiocarcinoma, colorectal cancer, gastric cancer, head and neck squamous cell carcinoma, and non-small cell lung cancer [23,24,25,26,31,32,33,34]. The gene discussed is YAP1; the disease is colorectal cancer.